James A. Robinson Jr.

Director at UroGen Pharma · 5 reported transactions in 2 companies · latest report Aug 26, 2026

Their trades


UroGen PharmaURGN	Exercised options — · 2,000 shares	Aug 26, 2026
UroGen PharmaURGN	Exercised options — · 2,000 shares	May 26, 2026
Eledon PharmaceuticalsELDN	Exercised options — · 3,430 shares	Jan 10, 2026
UroGen PharmaURGN	Exercised options — · 2,000 shares	Nov 26, 2025
UroGen PharmaURGN	Exercised options — · 2,000 shares	Feb 26, 2025

Exercised optionsUroGen Pharma

Aug 26, 2026 · URGN

2,000

Exercised optionsUroGen Pharma

May 26, 2026 · URGN

2,000

Jan 10, 2026 · ELDN

3,430

Exercised optionsUroGen Pharma

Nov 26, 2025 · URGN

2,000

Exercised optionsUroGen Pharma

Feb 26, 2025 · URGN

2,000

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at UroGen Pharma · 5 reported transactions in 2 companies · latest report Aug 26, 2026


UroGen PharmaURGN	Exercised options — · 2,000 shares	Aug 26, 2026
UroGen PharmaURGN	Exercised options — · 2,000 shares	May 26, 2026
Eledon PharmaceuticalsELDN	Exercised options — · 3,430 shares	Jan 10, 2026
UroGen PharmaURGN	Exercised options — · 2,000 shares	Nov 26, 2025
UroGen PharmaURGN	Exercised options — · 2,000 shares	Feb 26, 2025

Exercised optionsUroGen Pharma

Aug 26, 2026 · URGN

2,000

Exercised optionsUroGen Pharma

May 26, 2026 · URGN

2,000

Jan 10, 2026 · ELDN

3,430

Exercised optionsUroGen Pharma

Nov 26, 2025 · URGN

2,000

Exercised optionsUroGen Pharma

Feb 26, 2025 · URGN

2,000

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.